Canakinumab as first-line biological therapy in Still’s disease and differences between the systemic and the chronic-articular courses: Real-life experience from the international AIDA registry
Antonio Vitale, Valeria Caggiano, Maria Cristina Maggio, Giuseppe Lopalco, Giacomo Emmi, Jurgen Sota, Francesco La Torre, Piero Ruscitti, Elena Bartoloni, Giovanni Conti, Claudia Fabiani, Irene Mattioli, Carla Gaggiano, Fabio Cardinale, Lorenzo Dagna, Corrado Campochiaro, Roberto Giacomelli, Alberto Balistreri, Katerina Laskari, Abdurrahman Tufan, Gaafar Ragab, Ibrahim A. Almaghlouth, Ewa Więsik-Szewczyk, Rosa Maria Pereira, Bruno Frediani, Florenzo Iannone, Petros P. Sfikakis, Luca Cantarini
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 January 2023.
All research outputs
#15,862,459
of 23,570,677 outputs
Outputs from Frontiers in Medicine
#3,240
of 6,085 outputs
Outputs of similar age
#236,454
of 442,161 outputs
Outputs of similar age from Frontiers in Medicine
#205
of 443 outputs
Altmetric has tracked 23,570,677 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 6,085 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.6. This one is in the 35th percentile – i.e., 35% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 442,161 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 35th percentile – i.e., 35% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 443 others from the same source and published within six weeks on either side of this one. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.
